Rankings
▼
Calendar
IRD
Opus Genetics, Inc.
$346M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$14M
Net Income
-$19M
EPS (Diluted)
$-2.40
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$513,000
Balance Sheet
Total Assets
$18M
Total Liabilities
$31M
Stockholders' Equity
-$13M
Cash & Equivalents
$16M
← FY 2020
All Quarters
Q1 2021 →
IRD Q4 2020 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena
